Nobel Prize Recognizes Pioneering Immune System Discoveries
The Nobel Prize in medical science was awarded for revolutionary findings that illuminate how the body's defense network attacks dangerous pathogens while sparing the body's own cells.
Three esteemed researchers—from Japan Shimon Sakaguchi and US experts Dr. Brunkow and Fred Ramsdell—received this honor.
The research uncovered unique "sentinels" within the defense system that eliminate rogue defense cells capable of attacking the body.
These discoveries are now enabling innovative treatments for immune disorders and malignancies.
The laureates will share a monetary award valued at 11 million SEK.
Crucial Discoveries
"Their research has been essential for comprehending how the immune system functions and the reason we do not all suffer from serious autoimmune diseases," commented the chair of the Nobel Committee.
The trio's studies address a fundamental mystery: How does the defense system protect us from countless infections while leaving our healthy cells unharmed?
Our body's protection system uses white blood cells that scan for signs of infection, including viruses and germs it has not met before.
These defenders utilize sensors—called recognition units—that are generated randomly in countless combinations.
That gives the immune system the ability to combat a broad range of threats, but the unpredictability of the process unavoidably produces white blood cells that may attack the body.
Security Guards of the Immune System
Scientists earlier understood that a portion of these problematic defense cells were destroyed in the immune organ—the site where white blood cells develop.
This year's award honors the discovery of regulatory T-cells—described as the immune system's "security guards"—which travel through the body to disarm any immune cells that attack the body's own tissues.
It is known that this process fails in self-attack conditions such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.
The Nobel panel added, "The discoveries have established a new field of investigation and accelerated the creation of innovative therapies, for example for tumors and autoimmune diseases."
Regarding cancer, regulatory T-cells block the body from attacking the tumor, so studies are aimed at reducing their quantity.
In self-attack disorders, trials are exploring boosting regulatory T-cells so the organism is no longer being harmed. A similar approach could also be useful in reducing the risks of transplanted organ rejection.
Innovative Experiments
Professor Shimon Sakaguchi, from Osaka University, performed experiments on mice that had their thymus extracted, causing autoimmune disease.
The researcher demonstrated that introducing defense cells from other animals could stop the illness—implying there was a system for preventing defenders from harming the body.
Dr. Brunkow, from the a research center in a US city, and Fred Ramsdell, now at Sonoma Biotherapeutics in a California city, were studying an genetic autoimmune disease in mice and humans that led to the discovery of a gene critical for how regulatory T-cells operate.
"The groundbreaking work has revealed how the body's defenses is kept in check by regulatory T cells, preventing it from accidentally targeting the healthy cells," commented a prominent physiology specialist.
"The research is a remarkable example of how basic biological study can have far-reaching consequences for public health."
